Chemotherapy Foundation Symposium 2011
24 Nov 2011
Chemotherapy Foundation Symposium 2011
New trastuzumab combinations for HER2 positive breast cancer
Pomegranate extract for prostate cancer patients
New therapies for bladder cancer
Importance of genetic profiling and a tribute to Dr Judah Folkman
Antiangiogenic therapies for non-small cell lung cancer
Novel class of drug for ovarian cancer
Advances in T cell lymphoma treatment
Key procedures of molecular diagnosis
Cellular pathways in lung cancer and the need for personalised medicine
Toxicity and side effect prevention
Lifetime achievement award and future work